病例报告:PSMA PET/CT在前列腺癌随访中检出腹膜后血管瘤
本文报告一例72岁男性,有Gleason评分7(3+4)前列腺腺癌病史,根治性前列腺切除术后因PSA升高(0.12 μg/L)行PSMA PET/CT再分期,检出腹膜后PSMA高摄取病灶,经进一步检查及组织病理学分析证实为腹膜后血管瘤。作者强调前列腺癌PSMA PET/CT判读存在挑战,需全面考虑鉴别诊断。
要点
- 72岁男性前列腺腺癌根治术后PSA升至0.12 μg/L,行PSMA PET/CT再分期。
- PSMA PET/CT示腹膜后PSMA高摄取病灶,病理证实为腹膜后血管瘤。
- 作者强调PSMA PET/CT判读需全面考虑鉴别诊断。
核心结论
- 作者强调前列腺癌PSMA PET/CT判读存在挑战,需全面考虑以形成完整的鉴别诊断。
研究设计与样本
- 病例报告:一例72岁男性,有Gleason评分7(3+4)前列腺腺癌病史,根治性前列腺切除术后因PSA升高(0.12 μg/L)转诊行PSMA PET/CT再分期。
主要发现
- PSMA PET/CT检出腹膜后PSMA高摄取病灶,经进一步检查及组织病理学分析证实为腹膜后血管瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate-specific membrane antigen (PSMA) PET/CT scan has significantly improved the detection and staging of prostate cancer. We report a rare case of a 72-year-old man with a history of Gleason score 7 (3 + 4) prostate adenocarcinoma, status post radical prostatectomy, referred for restaging PSMA PET/CT scan due to rising PSA (0.12 μg/L). The scan revealed a PSMA-avid lesion in the retroperitoneum, later confirmed via further investigations and histopathological analysis to be a retroperitoneal hemangioma. This case emphasizes the challenges in interpreting PSMA PET/CT scan in prostate cancer and highlights the significance of thorough consideration in forming a comprehensive differential diagnosis.
引用
- Al Sawafi FM, Hasan OK, Bonert M, et al. A Case Report: PSMA PET/CT in Retroperitoneal Hemangioma. Clin Nucl Med. 2025. PMID: 39626294. doi:10.1097/RLU.0000000000005552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。